drugset / Trial / NCT03777696
Buccal Misoprostol and Intravenous Tranexamic Acid During Emergent Cesarean Delivery
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Purpose to evaluate the effects of buccal misoprostol with or without intravenous tranexamic acid (TA) in comparison with placebo on reducing post-partum hemorrhage in pregnant women undergoing emergent cesarean section
Timeline
- Start
- 2019-01-01
- Primary completion
- 2020-12-31
- Completion
- 2021-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Misoprostol | Other / unclassified | 400 ug | Other |
| Comparator | Tranexamic Acid | Small molecule | 1 g | Intravenous |
Indications
No indication recorded.